The Controlled Substances Act divides regulated drugs into five schedules based on two factors: accepted medical use and abuse potential. Schedule I means no accepted medical use and highest abuse potential (heroin, LSD); Schedule V means low abuse potential and accepted medical use (certain cough preparations, pregabalin). Scheduling determines whether you can get a prescription, how many refills are allowed, and what paperwork your prescriber must complete. Marijuana remains federally Schedule I despite widespread state legalization — a conflict with real legal consequences. Understanding where your medication falls on this framework helps you navigate prescriptions, refills, and travel rules.
What Is a Controlled Substance? DEA Drug Schedules Explained
If you have ever been handed a prescription that required a paper form, been told you could not refill a medication early, or wondered why marijuana is still federally illegal while your state sells it at a licensed shop — you are encountering the Controlled Substances Act in your daily life. Understanding the framework behind these rules helps you navigate prescriptions, understand your pharmacist's constraints, and have more informed conversations with your prescriber.
This guide explains what a controlled substance is, how the five-schedule classification system works, what scheduling means practically for patients, and where the framework creates ongoing tension with state law and medical practice.
What Is a Controlled Substance?
A controlled substance is any drug or chemical whose manufacture, possession, and use is regulated by the federal government under the Controlled Substances Act (CSA) of 1970. Signed into law by President Nixon, the CSA consolidated a patchwork of earlier federal drug laws into a single regulatory framework administered by two agencies: the Drug Enforcement Administration (DEA), which enforces the law, and the Department of Health and Human Services (HHS), which provides the medical and scientific recommendations that inform how drugs are classified.
The core purpose of scheduling is to distinguish between substances that have legitimate medical use and should be available by prescription, substances with accepted medical use that carry significant misuse risk and require special controls, and substances the federal government considers to have no legitimate medical purpose at all. Scheduling is not a simple ranking of how dangerous a drug is — it is a regulatory status that determines who can prescribe it, how a prescription must be written, how many times it can be refilled, and what penalties apply if it is possessed without authorization.
The DEA enforces the CSA, but the agency does not act alone. Any proposal to schedule or reschedule a drug requires a medical and scientific evaluation from HHS, which includes a recommendation from the FDA. The DEA is bound by HHS's finding on whether a drug has accepted medical use — if HHS determines it does, the DEA cannot place it in Schedule I. This interagency structure has shaped major scheduling disputes, including the ongoing debate over marijuana.
The Five Schedules: Quick Reference
The CSA places each regulated substance into one of five schedules. The criteria for each schedule involve two independent dimensions: accepted medical use in the United States, and potential for abuse. A drug can have accepted medical use and still be highly controlled — Schedule II exists precisely for this category.
| Schedule | Medical Use | Abuse Potential | Refills | Examples |
|---|---|---|---|---|
| Schedule I | None (federal) | Highest | Not prescribable | Heroin, LSD, MDMA, psilocybin, marijuana (federal) |
| Schedule II | Accepted | Highest among Rx drugs | None — new Rx each time | Oxycodone, fentanyl, Adderall, cocaine (topical) |
| Schedule III | Accepted | Moderate | Up to 5 in 6 months | Buprenorphine, ketamine, testosterone, anabolic steroids |
| Schedule IV | Accepted | Lower than III | Up to 5 in 6 months | Xanax, Valium, Ambien, tramadol, Ativan |
| Schedule V | Accepted | Lowest | Varies; some OTC in select states | Lyrica, codeine cough syrup (low concentration), Vimpat |
The Five Schedules in Depth
Schedule I substances cannot be prescribed by any physician. Research use requires a DEA Schedule I researcher registration, which is a lengthy and difficult process — a regulatory barrier that critics argue has hampered legitimate scientific investigation of psilocybin and MDMA as potential treatments for depression and PTSD. Several states have approved psilocybin-assisted therapy programs despite its federal Schedule I status, creating the same state-federal tension that exists with marijuana. MDMA was undergoing late-stage clinical trials as a potential PTSD treatment at the time of writing, raising the possibility of rescheduling based on that data.
⚠ Marijuana remains Schedule I under federal law despite legalization in many states. A federal employee using cannabis in a legal-state dispensary is still in violation of federal law. Banking, firearms purchases, and immigration status can all be affected by marijuana use regardless of state law.
Schedule II requires the most stringent prescription controls of any prescribable drug class. Most states require paper prescriptions printed on tamper-resistant security paper, though a growing number permit electronic prescribing of controlled substances (EPCS). A Schedule II prescription cannot be refilled — once the initial supply runs out, a brand-new prescription must be issued. Prescribers may not call in Schedule II prescriptions orally to a pharmacy except in genuine emergencies, and even then a written prescription must follow within 7 days. Note that cocaine's Schedule II status reflects a narrow, specific medical application as a topical vasoconstrictor-anesthetic used in surgery — it is not available for general prescribing.
Schedule III prescriptions may be refilled up to five times within six months of the date written. Prescribers may authorize refills orally by phone. Buprenorphine's Schedule III status has significant policy implications — it was placed here (rather than Schedule II) specifically to allow office-based prescribing for opioid use disorder treatment, since Schedule II would have required patients to obtain a new prescription every month. Ketamine's Schedule III status has facilitated the expansion of ketamine infusion clinics and FDA-approved esketamine (Spravato) nasal spray for treatment-resistant depression. Testosterone and other anabolic steroids are Schedule III due to abuse in athletic contexts, not because of high medical risk in appropriately supervised therapy.
Schedule IV shares refill rules with Schedule III: up to five refills within six months. Benzodiazepines — alprazolam, diazepam, clonazepam, lorazepam — constitute the bulk of Schedule IV prescriptions and remain among the most commonly prescribed controlled substances in the United States. Their placement in Schedule IV rather than Schedule II reflects their accepted medical use and the fact that they are less immediately dangerous in overdose than opioids, but benzodiazepines carry significant dependence risk and dangerous withdrawal characteristics (unlike opioids, benzodiazepine withdrawal can be fatal). Tramadol was moved from unscheduled to Schedule IV in 2014 following evidence of misuse. Many states track benzodiazepine prescriptions in Prescription Drug Monitoring Programs (PDMPs) regardless of their federal schedule. See our benzodiazepine comparison guide for more detail on the drugs in this class.
Schedule V includes drugs with legitimate medical uses and low — but not zero — misuse potential. Cough preparations containing less than 200 milligrams of codeine per 100 milliliters may be dispensed in certain states without a prescription, though the pharmacist must record the purchaser's information and there are quantity limits per purchase period. Pregabalin (Lyrica) is a notable case: it is Schedule V federally, but several states have placed it under stricter controls because of observed misuse, particularly among people with opioid use disorder who find it enhances the effects of opioids. This is an example of how federal scheduling and state scheduling can diverge in both directions. See also our guide to gabapentin, a related drug with its own complex scheduling landscape.
How a Drug Gets Scheduled — or Rescheduled
Scheduling is not permanent. The CSA provides a formal process for adding drugs to the schedules (scheduling), moving them to a different schedule (rescheduling), or removing them entirely (descheduling). Either the DEA or HHS may initiate this process, and any member of the public, including pharmaceutical companies, can petition for a scheduling review.
The process formally works as follows: the DEA requests a scientific and medical evaluation from HHS. HHS conducts a review through the FDA, examining factors including the drug's chemistry, its pharmacological effects, its pattern of abuse, the scope of its current abuse, what risk it poses to public health, the existence of physical or psychological dependence, and whether the substance is an immediate precursor to a scheduled drug. HHS provides a recommendation, and the DEA makes the final scheduling determination — though the DEA is legally bound to follow HHS's finding that a drug has no accepted medical use (which would require Schedule I placement).
Recent Rescheduling Examples
Hydrocodone combination products (2014): Before 2014, hydrocodone combination products like Vicodin — among the most prescribed drugs in the United States — were Schedule III, allowing refills and phone-in prescriptions. In 2014, the DEA moved them to Schedule II, reflecting evidence of widespread misuse and diversion. This was a significant change that immediately affected millions of patients, who suddenly needed a new written prescription for every supply rather than refills called in to the pharmacy.
Marijuana rescheduling debate: In 2024, HHS formally recommended that marijuana be rescheduled from Schedule I to Schedule III, based on its review of the evidence for accepted medical use and its abuse potential relative to Schedule I criteria. This recommendation, if finalized by the DEA, would be the first reclassification of marijuana since the CSA was enacted and would have substantial implications for research, taxation, and the legal conflict between state and federal cannabis law. The reclassification would not legalize recreational marijuana federally.
Tramadol (2014): Tramadol was added to Schedule IV in 2014 after years of evidence that it was being misused, particularly as an alternative to other opioids. Its reclassification extended prescription monitoring requirements and eliminated refill-at-will prescribing.
What Scheduling Means for Your Prescription
Scheduling has direct, practical consequences for how you receive and manage your medications. The most important patient-facing implications by schedule:
Traveling With Controlled Substances
Carrying a controlled substance across state lines while in possession of a valid prescription is generally legal, though there are practical precautions worth taking. Keep medications in their original pharmacy-labeled containers — a bottle labeled with your name, the drug name, and prescriber information is strong evidence of legitimate possession. Having a copy of the prescription or a letter from your prescriber is helpful for Schedule II medications, especially when traveling internationally.
International travel is more complicated: controlled substances — particularly opioids and benzodiazepines — are regulated very differently in other countries. Some countries that are signatories to international drug control treaties do not recognize U.S. prescriptions, and arriving with a Schedule II opioid without proper local authorization can result in seizure of the medication or criminal prosecution. The DEA recommends checking with the embassy of the destination country before traveling internationally with any controlled substance.
Flying domestically: the TSA does not actively search for drugs but is required to refer anything appearing to be a controlled substance violation to law enforcement. Controlled substances in properly labeled pharmacy containers are not flagged.
State vs. Federal: Where the Schedules Diverge
The federal scheduling framework sets a floor, not a ceiling. States may regulate drugs more strictly than the federal schedule allows but cannot be more permissive with federally controlled substances. This creates a two-layer regulatory system where your state's rules may differ substantially from what the CSA alone would suggest.
Marijuana: The Defining Conflict
Marijuana is the most prominent example of state-federal scheduling conflict. More than 40 states have legalized marijuana for medical use, and nearly half have legalized recreational adult use — yet marijuana remains Schedule I federally, a classification that carries consequences reaching well beyond criminal law. Federal employees may not use cannabis regardless of state law. Businesses that sell marijuana, even in states where it is fully legal, cannot use federally insured banks or deduct ordinary business expenses from federal taxes (under IRS tax code Section 280E, which disallows deductions for businesses trafficking Schedule I substances). People convicted of marijuana offenses at the federal level carry that record regardless of how their state has subsequently treated the same conduct.
The proposed reclassification to Schedule III would eliminate the Section 280E tax burden and open banking access for cannabis businesses, but would not create a federal legal market for recreational marijuana. See our guide to controlled substance regulations for additional detail.
Gabapentin: A Drug That Schedules Itself at the State Level
Gabapentin (Neurontin) is not a federally scheduled substance at all — it sits outside the CSA framework entirely. Yet as of 2025, more than a dozen states have individually scheduled gabapentin as a Schedule V controlled substance, based on observed patterns of misuse, particularly in combination with opioids. States including Kentucky, Tennessee, Michigan, and Virginia acted independently of any federal action, creating a patchwork where gabapentin is a controlled substance in some states and an unrestricted prescription drug in others. Pregabalin (Lyrica) occupies a similar but inverse position: federally Schedule V, but more strictly controlled in several states. Read our gabapentin guide for a full breakdown.
Frequently Asked Questions
Is marijuana a controlled substance?
Yes — federally, marijuana remains Schedule I under the Controlled Substances Act: no accepted medical use, high abuse potential. This federal classification has not changed despite widespread state legalization. As of 2024, the DEA proposed reclassifying marijuana to Schedule III based on an HHS recommendation — which would formally acknowledge accepted medical use and reduce federal penalties — but that reclassification had not been finalized at the time of writing. The conflict between federal Schedule I status and state-level legalization is not merely academic. It affects banking access for cannabis businesses (which cannot use federally insured banks), employment law for federal workers, immigration status, and firearms purchases (federal law prohibits drug users, including legal-state marijuana users, from purchasing firearms). State law cannot override federal scheduling — it simply means that federal enforcement is not being applied to state-licensed activity.
Can you get a controlled substance refilled early?
It depends on the schedule. Schedule II controlled substances — opioids like oxycodone and fentanyl, and stimulants like Adderall and Ritalin — cannot be refilled at all. A new prescription must be written and filled for each supply period, and most states require that prescription to be on tamper-resistant security paper or transmitted electronically. Schedule III and IV substances (buprenorphine, benzodiazepines like Xanax and Klonopin, tramadol) can be refilled up to five times within six months of the original prescription date. How early a pharmacy will fill a controlled substance is governed by state pharmacy board rules and individual pharmacy policy. Most pharmacies apply a fill window — commonly no earlier than 2 days before the expected run-out for most controlled substances — to flag potential misuse patterns. Running out early due to a legitimate change in circumstances (travel, prescriber changing the supply quantity) is a conversation to have with your prescriber directly, not at the pharmacy counter.
What happens if you're caught with a controlled substance without a prescription?
Possession of a controlled substance without a valid prescription is a federal crime and a crime in every state, though penalties vary substantially based on the schedule of the drug, the quantity, and state law. Federal penalties for simple possession of a Schedule I or II substance can include fines and prison time for a first offense; repeat offenses carry higher mandatory minimums. State penalties range widely — some states have decriminalized possession of small amounts of certain drugs, while others impose mandatory minimums. Possession with intent to distribute carries far more serious consequences and can be inferred from quantity, packaging, and other circumstances even without direct evidence of a sale. Carrying a legitimately prescribed controlled substance in a bottle labeled with someone else's name (borrowing a family member's medication, for example) creates legal risk during a police encounter, even if you have your own valid prescription for the same drug — which is one practical reason to keep all medications in their original labeled containers.
Why is cocaine a Schedule II drug?
Cocaine is Schedule II — not Schedule I — because it has a recognized, legitimate medical use: it is approved as a topical local anesthetic and vasoconstrictor, primarily used in ear, nose, and throat (ENT) surgery and certain nasal procedures. When applied to mucous membranes, cocaine simultaneously numbs tissue and constricts blood vessels, reducing surgical bleeding. This dual action — anesthesia plus vasoconstriction — has no exact equivalent among synthetic local anesthetics, which is why cocaine solutions (typically 4–10% concentration) remain in clinical use for specific surgical procedures. This is a narrow application with very controlled access — cocaine is not available for general prescribing in the usual sense. But this specific medical use is sufficient under the CSA's criteria to move it out of Schedule I (no accepted medical use) and into Schedule II (accepted medical use with highest abuse potential). Heroin, by contrast, has no accepted medical use in the United States — it is not approved here even though pharmaceutical heroin (diamorphine) is used medically in several other countries — keeping it at Schedule I.
What is the difference between physical dependence and addiction?
Physical dependence and addiction are related but distinct concepts that are frequently conflated, including in public discussions of controlled substances. Physical dependence means the body has adapted to the presence of a drug such that stopping it abruptly causes withdrawal symptoms. This is a predictable physiological adaptation that occurs with many medications — including non-controlled substances like beta-blockers and antidepressants. A patient taking an opioid for chronic pain will likely develop physical dependence; their nervous system adapts to expect the drug. Addiction is a neurobiological disorder characterized by compulsive drug-seeking and use despite harmful consequences, loss of control over use, and continued use even when the person recognizes it is damaging their life. Addiction involves lasting changes in the brain's reward circuitry that drive craving and behavior well beyond what physical need alone would explain. A patient who is physically dependent on a controlled substance and takes it exactly as prescribed is not addicted — they will require medical tapering if they stop, but their behavior is not compulsive or out of control. Conversely, someone can show patterns of addictive behavior with substances that cause minimal physical dependence. The distinction matters practically because physical dependence is managed medically (through tapering) while addiction is treated as a complex behavioral health condition that benefits from different clinical approaches. Many patients on long-term Schedule II or III medications are physically dependent — this is expected, does not indicate addiction, and does not mean the medication is inappropriate for them.
Identify a pill by imprint, color, or shape — or look up your medication's schedule and prescription requirements.
Look Up Controlled Substance Status